StoneX Group’s Silo Pharma SILO Stock Holding History

StoneX Group’s Portfolio SILO Stock Details SILO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-895	Closed	-$9.27K	–	1180
2025 Q3	$9.27K	Buy	+895	New	+$8.95K	﹤0.01%	901

Other funds holding SILO

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

StoneX Group's SILO Position: Q4 2025 in Review

StoneX Group sold out of Silo Pharma (SILO) in Q4 2025, closing a stake of 895 shares — an estimated $9.27K sold.

StoneX Group first reported a position in SILO in Q3 2025 and held it in 1 quarter. The position peaked at $9.27K in Q3 2025. 15 funds tracked by Wall St. Rank hold SILO as of Q4 2025.

StoneX Group reported no remaining Silo Pharma position as of Q4 2025 after selling out during the quarter.
StoneX Group sold 895 Silo Pharma shares in Q4 2025, an estimated $9.27K.
StoneX Group first reported a position in Silo Pharma in Q3 2025 and held it in 1 quarter.
StoneX Group's Silo Pharma position peaked at $9.27K in Q3 2025.
15 funds tracked by Wall St. Rank held Silo Pharma as of Q4 2025.

Based on StoneX Group's 13F filing for Q4 2025, filed 12 Feb 2026.